Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
$TLSA Anyone hear anything lately? Want to see this one go | mfayman | investorshub | 09/19/2023 3:40:14 PM |
$TLSA The now | TREND1 | investorshub | 09/19/2023 2:56:44 PM |
$TLSA Have a look at this | doolz | investorshub | 09/19/2023 2:15:58 PM |
$TLSA MomentumIts trading up | elmasry | investorshub | 09/19/2023 2:11:29 PM |
Price now last up | mfayman | investorshub | 09/19/2023 1:43:08 PM |
short squeeze article | Count Crypto | investorshub | 09/19/2023 1:22:43 PM |
$TLSA Have a look at this | Anita Dump | investorshub | 09/19/2023 10:38:45 AM |
$TLSA best news of the day | Count Crypto | investorshub | 09/19/2023 9:56:07 AM |
what does this mean? | doolz | investorshub | 09/19/2023 8:27:23 AM |
Do we have a winner?Turn around time? | subslover | investorshub | 09/19/2023 6:29:03 AM |
$TLSA and the shorts continue | Steve200747909 | investorshub | 09/19/2023 5:53:31 AM |
short squeeze all day | Ryguy008 | investorshub | 09/19/2023 2:44:06 AM |
Price gaining last up | TREND1 | investorshub | 09/19/2023 2:41:20 AM |
MomentumIts gaining | TREND1 | investorshub | 09/19/2023 2:32:54 AM |
$TLSA The trading | Anita Dump | investorshub | 09/19/2023 1:50:01 AM |
$TLSA Price trading | TREND1 | investorshub | 09/19/2023 1:47:07 AM |
$TLSA Do we have a winner?Turn around time? | Count Crypto | investorshub | 09/18/2023 11:58:17 PM |
$TLSA Thoughts on where this is headed? | Anita Dump | investorshub | 09/18/2023 8:42:45 PM |
short squeeze article | TheFinalCD | investorshub | 09/18/2023 8:32:34 PM |
When is this gonna take off? | TREND1 | investorshub | 09/18/2023 8:09:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ant...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...